Africa: dependable supply of HIV testing reagents needed for crucial early stage TB/HIV testing
This article was originally published in Clinica
Executive Summary
Lack of a regular supply of HIV testing reagents is hindering the progress of an integrated TB/HIV testing programme in Malawi. The problem is highlighted in a review of a 2003-2005 HIV testing plan recently published in The International Journal of Public Health 2007 (Bulletin of the World Health Organization). Despite this setback, the initiative's effort to scale up HIV testing for TB and HIV-positive TB patients (one among several objectives) was successful, achieving an increase in HIV tests from 15% in 2003 to 47% in 2005.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.